We are live on ! Find out more
HFCIX

H&F Corporate Investors X Portfolio holdings

AUM $2.8B
This Fund
S&P 500
This Quarter Est. Return
+2.44%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.18B
AUM Growth
–
Cap. Flow
+$4.2B
Cap. Flow %
100.55%
Top 10 Hldgs %
100%
Holding
1
New
1
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
MDLN
Medline Inc
MDLN
+$4.2B

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDLN
1
Medline Inc
MDLN
$31.2B
$4.18B 100%
+99,514,069
New +$4.2B

Similar funds

AGA
Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return
MC
Maplelane Capital New York $2.79B AUM 52.02% 1-Year Est. Return
HCC
Hill City Capital Boston, Massachusetts $2.8B AUM 79.27% 1-Year Est. Return
SHIM
Spruce House Investment Management New York $2.8B AUM 65.68% 1-Year Est. Return
AF
Aviso Financial Toronto, Ontario, Canada $2.82B AUM 24.96% 1-Year Est. Return
SAM
Smartleaf Asset Management Boston, Massachusetts $2.77B AUM 22% 1-Year Est. Return
LGP
Leonard Green & Partners Los Angeles, California $2.77B AUM 3.28% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return

H&F Corporate Investors X's Q4 2025 Portfolio in Review

As of Q4 2025, H&F Corporate Investors X held 1 position worth $4.18B. Its ten largest holdings account for 100% of the portfolio.

H&F Corporate Investors X deployed $4.2B of net new capital in Q4 2025, opening 1 new position. Its largest new stake was Medline Inc: 99,514,069 shares worth $4.18B.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • H&F Corporate Investors X's largest Q4 2025 buy was Medline Inc: 99,514,069 shares worth $4.18B.
  • H&F Corporate Investors X's ten largest holdings make up 100% of its $4.18B portfolio in Q4 2025.
  • H&F Corporate Investors X opened 1 new position and closed 0 in Q4 2025.

Based on H&F Corporate Investors X's 13F filing for Q4 2025, filed 13 Feb 2026.